IRIS Accounts Production v25.1.4.42 15210902 director 13.10.23 31.12.24 31.12.24 12.7.25 0 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh152109022023-10-12152109022024-12-31152109022023-10-132024-12-31152109022023-10-1215210902ns15:EnglandWales2023-10-132024-12-3115210902ns14:PoundSterling2023-10-132024-12-3115210902ns10:Director12023-10-132024-12-3115210902ns10:PrivateLimitedCompanyLtd2023-10-132024-12-3115210902ns10:SmallEntities2023-10-132024-12-3115210902ns10:Audited2023-10-132024-12-3115210902ns10:SmallCompaniesRegimeForDirectorsReport2023-10-132024-12-3115210902ns10:SmallCompaniesRegimeForAccounts2023-10-132024-12-3115210902ns10:FullAccounts2023-10-132024-12-3115210902ns10:OrdinaryShareClass12023-10-132024-12-3115210902ns10:RegisteredOffice2023-10-132024-12-3115210902ns5:CurrentFinancialInstruments2024-12-3115210902ns5:Non-currentFinancialInstruments2024-12-3115210902ns5:ShareCapital2024-12-3115210902ns5:RetainedEarningsAccumulatedLosses2024-12-3115210902ns5:LeaseholdImprovements2023-10-132024-12-3115210902ns5:LeaseholdImprovements2024-12-3115210902ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3115210902ns5:WithinOneYear2024-12-3115210902ns5:BetweenOneFiveYears2024-12-3115210902ns5:MoreThanFiveYears2024-12-3115210902ns5:AllPeriods2024-12-3115210902ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 15210902 (England and Wales)















Financial Statements

for the Period 13 October 2023 to 31 December 2024

for

PRENUVO LIMITED

PRENUVO LIMITED (REGISTERED NUMBER: 15210902)

Contents of the Financial Statements
FOR THE PERIOD 13 OCTOBER 2023 TO 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRENUVO LIMITED

Company Information
FOR THE PERIOD 13 OCTOBER 2023 TO 31 DECEMBER 2024







DIRECTOR: A Lacy





REGISTERED OFFICE: 10 John Street
London
WC1N 2EB





REGISTERED NUMBER: 15210902 (England and Wales)





AUDITORS: Oury Clark Chartered Accountants
Statutory Auditors
Herschel House
58 Herschel Street
Slough
SL1 1PG

PRENUVO LIMITED (REGISTERED NUMBER: 15210902)

Balance Sheet
31 DECEMBER 2024

Notes £    £   
FIXED ASSETS
Tangible assets 4 1,469,911

CURRENT ASSETS
Debtors 5 957,547

CREDITORS
Amounts falling due within one year 6 2,633,137
NET CURRENT LIABILITIES (1,675,590 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(205,679

)

CREDITORS
Amounts falling due after more than one year 7 88,611
NET LIABILITIES (294,290 )

CAPITAL AND RESERVES
Called up share capital 9 1
Retained earnings (294,291 )
SHAREHOLDERS' FUNDS (294,290 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 July 2025 and were signed by:





A Lacy - Director


PRENUVO LIMITED (REGISTERED NUMBER: 15210902)

Notes to the Financial Statements
FOR THE PERIOD 13 OCTOBER 2023 TO 31 DECEMBER 2024


1. STATUTORY INFORMATION

Prenuvo Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts have been prepared on the going concern basis in light of the fact that the director has received confirmation from the parent entity that it will provide adequate resources for the company to continue for a period of at least twelve months and one day from the date of the signing of this report.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses. Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Leasehold improvements - over the life of the lease

Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Basic financial assets and liabilities that are payable or receivable within one year, typically trade payables and receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PRENUVO LIMITED (REGISTERED NUMBER: 15210902)

Notes to the Financial Statements - continued
FOR THE PERIOD 13 OCTOBER 2023 TO 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4. TANGIBLE FIXED ASSETS
Improvemen
to
property
£   
Cost
Additions 1,469,911
At 31 December 2024 1,469,911
Net book value
At 31 December 2024 1,469,911

5. DEBTORS
£   
Amounts falling due within one year:
Other debtors 853,800
Prepayments 3,469
857,269

Amounts falling due after more than one year:
Other debtors 100,278

Aggregate amounts 957,547

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Amounts owed to group undertakings 2,623,137
Accrued expenses 10,000
2,633,137

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
£   
Deferred rent 88,611

PRENUVO LIMITED (REGISTERED NUMBER: 15210902)

Notes to the Financial Statements - continued
FOR THE PERIOD 13 OCTOBER 2023 TO 31 DECEMBER 2024


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
£   
Within one year 212,666
Between one and five years 850,667
In more than five years 2,126,667
3,190,000

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary 1 1

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Amy Enslin (Senior Statutory Auditor)
for and on behalf of Oury Clark Chartered Accountants

11. CAPITAL COMMITMENTS

At the reporting date, the company had entered into contractual commitments totaling £582,181 in respect of leasehold improvements relating to the new business premises. These commitments were not provided for in the financial statements as the work had not yet been undertaken at period end.

12. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

13. ULTIMATE CONTROLLING PARTY

The Company is wholly owned subsidiary of Prenuvo Inc., a company incorporated in the United States of America. Prenuvo Inc. is considered to be the parent company. The smallest group in which the results of the Company were consolidated as at 31 December 2024 was that headed by Prenuvo Inc., with its registered office at 2727 El Camino Real, Redwood City, CA 94061, United States of America.